THE CALANDRA REPORT: Subscribe $91 yearly SAN DIEGO — Inovio Pharmaceuticals (INO in USA), a DNA vaccine developer I sidestepped for four years, is having success with a Middle Eastern virus. INO shares are raging today. Inovio’s J, Joseph Kim, via a persistent biz-dev executive, Bernie Hertel, has been on me, professionally, since 2009. Inovio… Continue Reading
The Dig – Haywood Mining Team’s week in review
Gold Fibonacci Levels
Seven Generations Energy (VII.to) IPO raises $932 million
What the hell happened to Burkina?
Mackie acquires Jennings to get foothold in oilpatch